Myeloid cell-restricted insulin/IGF-1 receptor deficiency protects against skin inflammation

Journal of Immunology

Volumn 195, Issue 11, 2015, Pages 5296-5308

  Knuever, Jana ^a   Willenborg, Sebastian ^a   Ding, Xiaolei ^a   Akyuz, Mehmet D ^a   Partridge, Linda ^a,b   Niessen, Carien M ^a   Bruning, Jens C ^a,c,d   Eming, Sabine A ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MAX PLANCK INSTITUTE FOR BIOLOGY OF AGEING   (Germany)

^c MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; DODECYL SULFATE SODIUM; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 14; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; INSULIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DERMATITIS; GENE EXPRESSION; GRANULATION TISSUE; IRRITANT DERMATITIS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; ULTRAVIOLET B RADIATION; WOUND HEALING; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; CELL CULTURE; GENETICS; IMMUNOLOGY; INFLAMMATION; INSULIN RESISTANCE; KNOCKOUT MOUSE; MACROPHAGE; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; SIGNAL TRANSDUCTION; SKIN; ULTRAVIOLET RADIATION;

ANIMALS; CELLS, CULTURED; CYTOKINES; DERMATITIS; DIABETES MELLITUS, TYPE 2; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; SKIN; SODIUM DODECYL SULFATE; ULTRAVIOLET RAYS;

EID: 84948809049     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501237     Document Type: Article

References (38)

1. McNelis, J. C., and J. M. Olefsky. 2014. Macrophages, immunity, and metabolic disease. Immunity 41: 36-48.
2. Woodcock, K. J., K. Kierdorf, C. A. Pouchelon, V. Vivancos, M. S. Dionne, and F. Geissmann. 2015. Macrophage-derived upd3 cytokine causes impaired glucose homeostasis and reduced lifespan in Drosophila fed a lipid-rich diet. Immunity 42: 133-144.
3. Lavin, Y., D. Winter, R. Blecher-Gonen, E. David, H. Keren-Shaul, M. Merad, S. Jung, and I. Amit. 2014. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159: 1312-1326.
4. Baumgartl, J., S. Baudler, M. Scherner, V. Babaev, L. Makowski, J. Suttles, M. McDuffie, K. Tobe, T. Kadowaki, S. Fazio, et al. 2006. Myeloid lineage cellrestricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis. Cell Metab. 3: 247-256.
5. Mauer, J., B. Chaurasia, L. Plum, T. Quast, B. Hampel, M. Bluher, W. Kolanus, C. R. Kahn, and J. C. Bruning. 2010. Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance. PLoS Genet. 6: e1000938.
6. Nolan, C. J., P. Damm, and M. Prentki. 2011. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378: 169-181.
7. Falanga, V. 2005. Wound healing and its impairment in the diabetic foot. Lancet 366: 1736-1743.
8. Duff, M., O. Demidova, S. Blackburn, and J. Shubrook. 2015. Cutaneous manifestations of diabetes mellitus. Clin. Diabetes 33: 40-48.
9. Demirseren, D. D., S. Emre, G. Akoglu, D. Arpac, A. Arman, A. Metin, and B. Cakr. 2014. Relationship between skin diseases and extracutaneous complications of diabetes mellitus: clinical analysis of 750 patients. Am. J. Clin. Dermatol. 15: 65-70.
10. Brownlee, M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
11. Baker, J., J. P. Liu, E. J. Robertson, and A. Efstratiadis. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82.
12. Stachelscheid, H., H. Ibrahim, L. Koch, A. Schmitz, M. Tscharntke, F. T. Wunderlich, J. Scott, C. Michels, C. Wickenhauser, I. Haase, et al. 2008. Epidermal insulin/IGF-1 signalling control interfollicular morphogenesis and proliferative potential through Rac activation. EMBO J. 27: 2091-2101.
13. Gunschmann, C., H. Stachelscheid, M. D. Akyuz, A. Schmitz, C. Missero, J. C. Bruning, and C. M. Niessen. 2013. Insulin/IGF-1 controls epidermal morphogenesis via regulation of FoxO-mediated p63 inhibition. Dev. Cell 26: 176-187.
14. Aghdam, S. Y., S. A. Eming, S. Willenborg, B. Neuhaus, C. M. Niessen, L. Partridge, T. Krieg, and J. C. Bruning. 2012. Vascular endothelial insulin/IGF-1 signaling controls skin wound vascularization. Biochem. Biophys. Res. Commun. 421: 197-202.
15. Roth, D., M. Piekarek, M. Paulsson, H. Christ, W. Bloch, T. Krieg, J. M. Davidson, and S. A. Eming. 2006. Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair. Am. J. Pathol. 168: 670-684.
16. Hoffmann, D. C., S. Willenborg, M. Koch, D. Zwolanek, S. Muller, A. K. Becker, S. Metzger, M. Ehrbar, P. Kurschat, M. Hellmich, et al. 2013. Proteolytic processing regulates placental growth factor activities. J. Biol. Chem. 288: 17976-17989.
17. Bar, R. S., P. Gorden, J. Roth, C. R. Kahn, and P. De Meyts. 1976. Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting. J. Clin. Invest. 58: 1123-1135.
18. Costa Rosa, L. F. B. P., D. A. Safi, Y. Cury, and R. Curi. 1996. The effect of insulin on macrophage metabolism and function. Cell Biochem. Funct. 14: 33-42.
19. Renier, G., I. Clément, A. C. Desfaits, and A. Lambert. 1996. Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production. Endocrinology 137: 4611-4618.
20. Nakae, J., Y. Kido, and D. Accili. 2001. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr. Rev. 22: 818-835.
21. White, M. F. 2003. Insulin signaling in health and disease. Science 302: 1710-1711.
22. Bruning, J. C., M. D. Michael, J. N. Winnay, T. Hayashi, D. Hörsch, D. Accili, L. J. Goodyear, and C. R. Kahn. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2: 559-569.
23. Willenborg, S., T. Lucas, G. van Loo, J. A. Knipper, T. Krieg, I. Haase, B. Brachvogel, M. Hammerschmidt, A. Nagy, N. Ferrara, et al. 2012. CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair. Blood 120: 613-625.
24. Kim, C., Y. Sano, K. Todorova, B. A. Carlson, L. Arpa, A. Celada, T. Lawrence, K. Otsu, J. L. Brissette, J. S. Arthur, and J. M. Park. 2008. The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro-and anti-inflammatory gene expression. Nat. Immunol. 9: 1019-1027.
25. Thepen, T., A. J. van Vuuren, R. C. M. Kiekens, C. A. Damen, W. C. Vooijs, and J. G. J. van De Winkel. 2000. Resolution of cutaneous inflammation after local elimination of macrophages. Nat. Biotechnol. 18: 48-51.
26. Cramer, T., Y. Yamanishi, B. E. Clausen, I. Fö rster, R. Pawlinski, N. Mackman, V. H. Haase, R. Jaenisch, M. Corr, V. Nizet, et al. 2003. HIF-1a is essential for myeloid cell-mediated inflammation. Cell 112: 645-657.
27. Lucas, T., A. Waisman, R. Ranjan, J. Roes, T. Krieg, W. Muller, A. Roers, and S. A. Eming. 2010. Differential roles of macrophages in diverse phases of skin repair. J. Immunol. 184: 3964-3977.
28. Clausen, B. E., C. Burkhardt, W. Reith, R. Renkawitz, and I. Förster. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8: 265-277.
29. Cela, E. M., A. Friedrich, M. L. Paz, S. I. Vanzulli, J. Leoni, and D. H. González Maglio. 2015. Time-course study of different innate immune mediators produced by UV-irradiated skin: comparative effects of short and daily versus a single harmful UV exposure. Immunology 145: 82-93.
30. Wicks, K., T. Torbica, and K. A. Mace. 2014. Myeloid cell dysfunction and the pathogenesis of the diabetic chronic wound. Semin. Immunol. 26: 341-353.
31. Seitz, O., C. Schurmann, N. Hermes, E. Muller, J. Pfeilschifter, S. Frank, and I. Goren. 2010. Wound healing in mice with high-fat diet-or ob gene-induced diabetes-obesity syndromes: a comparative study. Exp. Diabetes Res. 2010: 476969.
32. Wood, S., V. Jayaraman, E. J. Huelsmann, B. Bonish, D. Burgad, G. Sivaramakrishnan, S. Qin, L. A. DiPietro, A. Zloza, C. Zhang, and S. H. Shafikhani. 2014. Pro-inflammatory chemokine CCL2 (MCP-1) promotes healing in diabetic wounds by restoring the macrophage response. PLoS One 9: e91574.
33. Selman, C., S. Lingard, A. I. Choudhury, R. L. Batterham, M. Claret, M. Clements, F. Ramadani, K. Okkenhaug, E. Schuster, E. Blanc, et al. 2008. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J. 22: 807-818.
34. Nair, M. G., Y. Du, J. G. Perrigoue, C. Zaph, J. J. Taylor, M. Goldschmidt, G. P. Swain, G. D. Yancopoulos, D. M. Valenzuela, A. Murphy, et al. 2009. Alternatively activated macrophage-derived RELM-a is a negative regulator of type 2 inflammation in the lung. J. Exp. Med. 206: 937-952.
35. Pesce, J. T., T. R. Ramalingam, M. S. Wilson, M. M. Mentink-Kane, R. W. Thompson, A. W. Cheever, J. F. Urban, Jr., and T. A. Wynn. 2009. Retnla (relmalpha/fizz1) suppresses helminth-induced Th2-type immunity. PLoS Pathog. 5: e1000393.
36. Wullschleger, S., R. Loewith, and M. N. Hall. 2006. TOR signaling in growth and metabolism. Cell 124: 471-484.
37. Solomon, D. H., E. Massarotti, R. Garg, J. Liu, C. Canning, and S. Schneeweiss. 2011. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA 305: 2525-2531.
38. Armstrong, A. W., C. T. Harskamp, and E. J. Armstrong. 2013. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol. 149: 84-91.